Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Brain Tumor, Primary: early-phase trial registry
4 of 4 indexed Brain Tumor, Primary trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Brain Tumor, Primary: 4 US clinical trials tracked, 4 recruiting.
Brain Tumor, Primary is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is GT Medical Technologies, running 1 of these trials.
Enrollment posture brief
Registry condition brain-tumor-primary
OPEN 4 | RECR 100% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Brain Tumor, Primary lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Brain Tumor, Primary on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Brain Tumor, Primary is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
GT Medical Technologies
NCT04427384
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Duke University
NCT05480644
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Northwell Health
NCT03213002
Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients
Washington University School of Medicine
NCT06185686
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Brain Tumor, Primary records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Brain Tumor, Primary trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Brain Tumor, Primary page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Brain Tumor, Primary trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- GT Medical Technologies sponsors the most Brain Tumor, Primary trials on record, review their full trial history before evaluating a specific study. See GT Medical Technologies's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brain Tumor, Primary condition card totals 4 registered trials; most-linked intervention Resting State MRI/Precision functional mapping; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.